To further investigate the inhibitory effect of Nanog on Rad51 in human cancer cells, we manipulated Rad51 expression in HeLa cells and found that gradual increase in Rad51 was well correlated with the extent of decrease in Nanog-activated γH2AX (Fig. 2f–g). The gene discussed is RAD51; the disease is cancer.